Fund Holdings — Sofinnova Investments, Inc.

Total Portfolio Value
$1.87B
Total Bought
$344.76M
Total Sold
$678.24M
Net Transaction
-$333.47M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q1 2026
▲▼
Q2 2026
▲▼
Change
▲▼
Q1 2026
▲▼
Q2 2026
▲▼
Weight (%)
▲▼
Change
▲▼
Natera Inc(NTRA)1,550,2801,550,2800310,040420,82422.48%+110,783
Genmab A/S(GMAB)752,2614,045,215+3,292,95420,183111,1225.94%+90,939
Seaport Therapeutics Inc03,564,871+3,564,871077,4294.14%+77,429
Gilead Sciences Inc(GILD)0343,100+343,100043,3472.32%+43,347
Arrivent BioPharma Inc(AVBP)1,696,7521,696,752039,14458,9453.15%+19,801
Rapport Therapeutics Inc(RAPP)1,904,4081,904,408059,58979,3574.24%+19,768
Anaptysbio Inc248,253493,536+245,28313,76833,3141.78%+19,546
BioAge Labs Inc(BIOA)2,293,7882,293,788040,11856,2213.00%+16,102
Veradermics Inc(MANE)73,315148,993+75,6784,63018,3170.98%+13,687
Nurix Therapeutics Inc(NRIX)0524,098+524,098012,7150.68%+12,715
Design Therapeutics Inc(DSGN)0865,135+865,135012,5190.67%+12,519
First Tracks Biotherapeutics0565,199+565,199011,3720.61%+11,372
Abbott Laboratories0122,998+122,998011,1610.60%+11,161
Arcus Biosciences Inc(RCUS)923,086945,690+22,60419,93929,1561.56%+9,217
Vera Therapeutics Inc(VERA)2,793,9872,793,9870112,402119,8906.40%+7,488
Pharvaris N V
COM
818,328881,299+62,97123,11830,4751.63%+7,358
Dyne Therapeutics Inc(DYN)1,633,8971,658,384+24,48729,62336,8331.97%+7,210
Sionna Therapeutics Inc(SION)0144,432+144,43206,3540.34%+6,354
Rhythm Pharmaceuticals Inc(RYTM)450,096408,027-42,06939,14545,3032.42%+6,158
Disc Medicine Inc(IRON)78,320146,239+67,9195,00810,6960.57%+5,688
Tenax Therapeutics Inc(TENX)104,400500,039+395,6391,6697,2760.39%+5,606
Definium Therapeutics Inc(DFTX)344,166255,903-88,2636,50512,0380.64%+5,533
Absci Corporation0337,400+337,40003,9100.21%+3,910
Axsome Therapeutics Inc.(AXSM)212,747160,429-52,31835,95839,2682.10%+3,310
Edgewise Therapeutics Inc(EWTX)386,498380,923-5,57512,17515,4770.83%+3,302
Immatics N.V(IMTX)3,630,4543,669,346+38,89235,72437,1701.99%+1,447
Inhibrx Biosciences Inc(INBX)406,029303,103-102,92627,29728,7191.53%+1,422
Sagimet Biosciences Inc(SGMT)0166,667+166,66701,2880.07%+1,288
Aktis Oncology Inc(AKTS)032,436+32,43601,0450.06%+1,045
Onkure Therapeutics Inc(OKUR)141,700321,692+179,9925871,4670.08%+880
Jade Biosciences Inc107,391107,39101,5092,3860.13%+877
Mirum Pharmaceuticals Inc(MIRM)27,59127,59102,5493,2300.17%+681
Septerna Inc(SEPN)47,50647,50601,1421,5910.08%+449
Savara Inc(SVRA)364,763364,76301,9922,2470.12%+255
Heartflow Inc(HTFL)05,079+5,07901490.01%+149
ImageneBio Inc(IMA)31,88431,88401591880.01%+29
Bolt Biotherapeutics Inc137,721137,72105565300.03%-26
Zymeworks Inc(ZYME)1,6100-1,610400—-40
Wave Life Sciences Ltd(WVE)189,253189,25301,3721,1000.06%-273
Soleno Therapeutics Inc14,6890-14,6894920—-492
Immunome Inc(IMNM)1,701,9041,720,316+18,41237,22136,4531.95%-767
Supernus Pharmaceuticals(SUPN)954,3091,036,328+82,01949,32848,2002.57%-1,129
Acadia Pharmaceuticals Inc78,5510-78,5511,7490—-1,749
Establishment Labs Hldgs Inc(ESTA)33,9300-33,9301,9270—-1,927
Nextcure Inc222,654222,65402,3783560.02%-2,022
Vaxcyte Inc(PCVX)50,6000-50,6002,9400—-2,940
IDEAYA Biosciences Inc(IDYA)1,131,786925,119-206,66737,71134,4791.84%-3,232
Nektar Therapeutics(NKTR)509,546471,763-37,78336,66232,9341.76%-3,728
Harmony Biosciences Hldgs Inc(HRMY)152,6950-152,6954,2770—-4,277
Cytokinetics Inc(CYTK)91,7910-91,7916,0500—-6,050
Tyra Biosciences Inc(TYRA)204,01532,267-171,7487,8141,0310.06%-6,783
AxoGen Inc(AXGN)210,6650-210,6656,9790—-6,979
Tango Therapeutics Inc(TNGX)395,0810-395,0818,2650—-8,265
Ultragenyx Pharmaceutical In(RARE)3,145,8881,717,505-1,428,38365,90657,3473.06%-8,559
Oric Pharmaceuticals Inc(ORIC)679,5780-679,5788,6100—-8,610
Compass Therapeutics Inc(CMPX)2,056,1610-2,056,16110,8770—-10,877
Roivant Sciences Ltd(ROIV)477,9950-477,99513,2400—-13,240
Stryker Corporation(SYK)44,4800-44,48014,6160—-14,616
Xenon Pharmaceuticals Inc(XENE)305,2160-305,21617,7480—-17,748
Praxis Precision Medicines I(PRAX)63,6806,440-57,24020,5172,1560.12%-18,361
BioMarin Pharmaceutical Inc(BMRN)781,982358,568-423,41444,17420,5171.10%-23,657
Dexcom Inc(DXCM)393,5760-393,57624,7170—-24,717
Jazz Pharmaceuticals PLC(JAZZ)598,327365,341-232,986113,11488,0364.70%-25,077
BridgeBio Pharma Inc(BBIO)409,1830-409,18330,3860—-30,386
Alcon AG(ALC)729,972255,824-474,14855,00317,1660.92%-37,838
Insmed Inc(INSM)346,075158,398-187,67756,59016,8880.90%-39,702
Cogent Biosciences Inc(COGT)2,113,5511,035,148-1,078,40381,35140,0602.14%-41,290
Celcuity Inc(CELC)366,1750-366,17541,7950—-41,795
Biogen Inc(BIIB)229,5210-229,52142,0780—-42,078
United Therapeutics Corp Del(UTHR)160,07076,489-83,58194,91841,4442.21%-53,474
Bristol-Myers Squibb Co(BMY)1,988,721876,970-1,111,751120,61650,5312.70%-70,085
AstraZeneca PLC(AZN)456,0310-456,03189,9380—-89,938
Page 1 of 1
Sofinnova Investments, Inc. — 13F Holdings — Q2 2026 | TickerTrail